Zobrazeno 1 - 10
of 32
pro vyhledávání: '"Joshua D, Di Vincenzo"'
Autor:
Angela T.H. Kwan, Gia Han Le, Ziji Guo, Felicia Ceban, Kayla M. Teopiz, Taeho Greg Rhee, Roger Ho, Joshua D. Di Vincenzo, Sebastian Badulescu, Shakila Meshkat, Bing Cao, Joshua D. Rosenblat, Donovan A. Dev, Lee Phan, Mehala Subramaniapillai, Roger S. McIntyre
Publikováno v:
Annals of General Psychiatry, Vol 23, Iss 1, Pp 1-8 (2024)
Abstract Background Post-COVID-19 Condition (PCC), as defined by the World Health Organization (WHO), currently lacks any regulatory-approved treatments and is characterized by persistent and debilitating cognitive impairment and mood symptoms. Addit
Externí odkaz:
https://doaj.org/article/f10966f3de0249f383bcf2ac99a67247
Autor:
Muhammad Youshay Jawad, Saleha Qasim, Menglu Ni, Ziji Guo, Joshua D. Di Vincenzo, Giacomo d’Andrea, Aniqa Tabassum, Andrea Mckenzie, Sebastian Badulescu, Iria Grande, Roger S. McIntyre
Publikováno v:
Brain Sciences, Vol 13, Iss 6, p 909 (2023)
Bipolar depression remains a clinical challenge with a quarter of patients failing to respond to initial conventional treatments. Although ketamine has been extensively studied in unipolar depression, its role in bipolar disorder remains inconclusive
Externí odkaz:
https://doaj.org/article/47b9080679064e67bff8cc9b972d03c7
Autor:
Felicia Ceban, Dana Kulzhabayeva, Nelson B. Rodrigues, Joshua D. Di Vincenzo, Hartej Gill, Mehala Subramaniapillai, Leanna M.W. Lui, Bing Cao, Rodrigo B. Mansur, Roger C. Ho, Matthew J. Burke, Taeho Greg Rhee, Joshua D. Rosenblat, Roger S. McIntyre
Publikováno v:
Brain, Behavior, and Immunity. 111:211-229
Autor:
Shakila, Meshkat, Roger C, Ho, Bing, Cao, Kayla M, Teopiz, Joshua D, Rosenblat, Taeho Greg, Rhee, Joshua D, Di Vincenzo, Felicia, Ceban, Muhammad Youshay, Jawad, Roger S, McIntyre
Publikováno v:
Journal of Affective Disorders. 323:598-606
Ketamine is a NMDA receptor antagonist that has a rapid acting antidepressant effect with high efficacy in treatment-resistant patients. Ketamine is a beneficial antidepressant for many individuals with depression, but not all of the patients respond
Autor:
Shakila Meshkat, Sipan Haikazian, Joshua D. Di Vincenzo, Farhan Fancy, Danica Johnson, David Chen-Li, Roger S. McIntyre, Rodrigo Mansur, Joshua D. Rosenblat
Publikováno v:
The World Journal of Biological Psychiatry. :1-13
Autor:
Isak, Joneborg, Yena, Lee, Joshua D, Di Vincenzo, Felicia, Ceban, Shakila, Meshkat, Leanna M W, Lui, Farhan, Fancy, Joshua D, Rosenblat, Roger S, McIntyre
Publikováno v:
Journal of Affective Disorders. 315:105-112
Few studies have evaluated the efficacy of ketamine-assisted psychotherapy (KAP) in the treatment of treatment-resistant depression (TRD) and substance use disorders (SUD).A systematic review of clinical trials reporting on the efficacy of KAP and di
Autor:
Yazen Alnefeesi, David Chen-Li, Ella Krane, Muhammad Youshay Jawad, Nelson B. Rodrigues, Felicia Ceban, Joshua D. Di Vincenzo, Shakila Meshkat, Roger C.M. Ho, Hartej Gill, Kayla M. Teopiz, Bing Cao, Yena Lee, Roger S. McIntyre, Joshua D. Rosenblat
Publikováno v:
Journal of Psychiatric Research. 151:693-709
Ketamine is a promising therapeutic option in treatment-resistant depression (TRD). The acute efficacy of ketamine in TRD has been demonstrated in replicated randomised-controlled trials (RCTs), but the generalizability of RCT data to real-world prac
Publikováno v:
Psychedelics as Psychiatric Medications ISBN: 0192863606
Chapter 9 examines the history, clinical evidence, and proposed mechanisms of action of ketamine formulations as treatments for mood disorders such as treatment-resistant depression (TRD) and suicidality associated with major depressive disorder (MDD
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a30176ecbba1f19ea16e223ccff9f367
https://doi.org/10.1093/med/9780192863607.003.0009
https://doi.org/10.1093/med/9780192863607.003.0009
Autor:
Marcus A, Doyle, Susan, Ling, Leanna M W, Lui, Paul, Fragnelli, Kayla M, Teopiz, Roger, Ho, Joshua D, Di Vincenzo, Joshua D, Rosenblat, Emily S, Gillissie, Danica, Nogo, Felicia, Ceban, Muhammad Youshay, Jawad, Roger S, McIntyre
Publikováno v:
Expert Opinion on Drug Safety. 21:733-743
Hallucinogen persisting perception disorder (HPPD) affects a subset of persons who use hallucinogens and is defined as the repeated experience of hallucinations and other perceptual disturbances as a result of prior intoxications. As select hallucino
Autor:
Gia Han Le, Emily S. Gillissie, Taeho Greg Rhee, Bing Cao, Yazen Alnefeesi, Ziji Guo, Joshua D. Di Vincenzo, Muhammad Youshay Jawad, Andrew M. March, Ranuk Ramachandra, Leanna M.W. Lui, Roger S. McIntyre
Schizophrenia is a mental illness that can disrupt emotions, perceptions, and cognition and reduce quality of life. The classical approach to treat schizophrenia is to use typical and atypical antipsychotics; however, limitations include low efficacy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::514a597f3c15908ab5778b83c72667cb